FOSSE MASTER ISSUER PLC
(a public company incorporated with limited liability in England and Wales with registered number 05925693) (the Company)
Publication of Final Terms and Pricing Supplement
The following final terms (the Final Terms) are available for viewing:
Issue of £750,000,000 Series 2024-1 Class A1 Floating Rate Notes due October 2072 (Reg S ISIN Code: XS2811884530) under the Residential Mortgage Backed Note Programme (the Programme) of the Company.
To view the full Final Terms document, please click on or paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/4081O_1-2024-5-14.pdf
A copy of the above Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The Final Terms will also shortly be available for inspection at:
https://www.santander.co.uk/about-santander/investor-relations/fosse-master-trust.
The following pricing supplement (the Pricing Supplement) is available for viewing:
Issue of £10,000,000 Series 2024-1 Class Z Variable Funding Note under the Programme of the Company.
To view the full Pricing Supplement document, please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/4081O_2-2024-5-14.pdf
The Pricing Supplement will also be available for viewing at:
https://www.santander.co.uk/about-santander/investor-relations/fosse-master-trust.
In addition, certain amendments have been made to the mortgage sale agreement and the master definitions and construction schedule and will shortly be available for inspection at https://www.santander.co.uk/about-santander/investor-relations/fosse-master-trust.
For further information, please contact:
Medium Term Funding
Santander UK plc
2 Triton Square
Regent's Place
London NW1 3AN
Email: mtf@santander.co.uk
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Final Terms, the Pricing Supplement and the base prospectus published in relation to the Programme on 16 June 2023 as supplemented on 5 July 2023 (the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries only (as further specified in the Final Terms, the Pricing Supplement and the Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms, the Pricing Supplement and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms, the Pricing Supplement and the Prospectus, you must ascertain from the Final Terms, the Pricing Supplement and the Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in, the United States of America, or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act) except in transactions that occur outside the United States to persons other than U.S. persons in accordance with Regulation S or in other transactions exempt from registration under the Securities Act and, in each case, in compliance with applicable securities laws.